Quality of life after risk reducing mastectomy in a Portuguese cohort of BRCA pathogenic/likely pathogenic variant carriers

• Tipo: Artigo em Revista Científica Internacional
• Data: 2025

Autores

Raposo, M (Autor) Outra; peleteiro, b (Autor) FMUP; Magalhaes, A (Autor) Outra; Torres, S (Autor) Outra; Insua-Pereira, I (Autor) Outra; Guimaraes, R (Autor) Outra; Garrido, L (Autor) Outra; Costa, S (Autor) Outra; Fougo, JL (Autor) Outra

Revista

Título: Journal of Cancer Research and Clinical Oncology

Vol. 151

ISSN: 0171-5216

Editora: Springer Nature

Indexação

ISI Web of Knowledge - 0 Citações

Scopus - 0 Citações

Outras Informações

ID Authenticus: P-019-0SG

DOI: 10.1007/s00432-025-06231-9

Abstract (EN): PurposeWomen with pathogenic/likely pathogenic (P/LP) variants in BRCA1/2 genes have an increased lifetime risk of breast and ovarian cancer. Cancer risk management options include intensive breast surveillance (IBS) and risk reducing mastectomy (RRM). This study aims to compare the effect of these strategies on quality of life, anxiety, and depression to enhance shared decision-making.MethodsWe retrospectively analysed clinical records of 221 women with P/LP variants in BRCA1/2 genes, from 2007 to 2024. A total of 169 questionnaires containing Hospital Anxiety and Depression Scale (HADS) and BREAST-Q were sent, from May to September 2024. Ninety-nine women, 48 who had undergone RRM and 51 who had opted for IBS, completed the questionnaires. Patient-reported outcome measures (PROMs) were compared based on their choice.ResultsSignificant differences were found in age at genetic testing and personal history of breast cancer between the groups. In BREAST-Q, the IBS group reported higher scores, with statistically significant differences for Satisfaction with Breasts and Physical Well-Being: Chest. These differences were only observed in the group of women without personal breast cancer history who underwent RRM.ConclusionsNo significant differences were found in psychologic distress levels between the IBS and RRM group. Although RRM is an effective method for reducing breast cancer risk in women with P/LP variants in BRCA1/2 genes, carriers should be informed of its impact on quality of life. Notably, once a woman is diagnosed with breast cancer, these differences lose effect.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 13